Priority Date: 08.12.11 (US 201161568240P)

MAMMALIAN FETAL PULMONARY CELLS AND THERAPEUTIC USE OF SAME

  • Application ID: EP12813990
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicant

Company dna yeda research and development co ltd
Technology Transfer Office

Attorney

Employment test 51 - 200 employees
Company dna dennemeyer
operating since 1962
1054.48
Headquarter in Howald and 13 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Dennemeyer SA is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 170 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 08.12.2011 - Priority Date (US 201161568240P)
  • 13.06.2013 - Publication A1 (WO2013084190)
  • 15.10.2014 - Publication A1 (EP2788009)
  • 25.05.2016 - Publication B1 (EP2788009)

IPC Classification